drugIndia
Cart
Glyree MV1 Tablet PR

Glyree MV1 Tablet PR

Metformin (500mg) + Glimepiride (1mg) + Voglibose (0.2mg)

Ipca Laboratories Ltd
Kidney Disease
139.84174.8020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 77%
Best Alternative100% Match

Glimison-VM 1 Tablet SR

Unison Pharmaceuticals Pvt Ltd

Voglibose 0.2mg
Glimison-VM 1 Tablet SR

Pack Size

1 units

Price

31.6020% off
Glimison-VM 1 Tablet SR is 100% same as Glyree MV1 Tablet PR
Better ValueSame QualitySame Effectiveness

Save ₹108

that's 77% off!

composition
  1. Voglibose 0.2mg
  2. Glimepiride 1mg
  3. Metformin 500mg
Buy Now
139.8420% OFF
174.80

About This Medicine

Product description & overview

Glyree MV1 Tablet PR: A Combination Treatment for Type 2 Diabetes

Glyree MV1 Tablet PR is a once-daily combination tablet containing Glimepiride (1mg), Metformin (500mg), and Voglibose (0.2mg) designed to improve blood sugar control in adults with Type 2 diabetes.

How it Works:
* Glimepiride: This sulfonylurea medication helps stimulate insulin release from the pancreas, reducing high blood glucose levels.
* Metformin: A first-line oral treatment for type 2 diabetes, metformin lowers hepatic glucose production and promotes cellular glucose uptake, further aiding in blood sugar regulation.
* Voglibose: This acarbose-like agent slows intestinal glucose absorption, contributing to improved glycemic control.

Benefits: Glyree MV1 Tablet PR is a comprehensive solution for managing Type 2 diabetes by addressing multiple pathways to reduce blood sugar levels effectively.

Important Notes: This medication should be taken only as prescribed by a healthcare professional and may not be suitable for all individuals. Always consult with your physician for personalized recommendations and potential interactions.

Active composition

Metformin 500 mg

+2 more active ingredients

About Metformin

Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.

How It Works

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Medicine Strength
500 mg

All Active Ingredients

Metformin500 mg
Glimepiride1 mg
Voglibose0.2 mg

Glimepiride

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Voglibose

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glyree MV1 Tablet PR.

High Risk

Pregnancy

Glyree MV1 Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glyree MV1 Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Glyree MV1 Tablet PR may be needed. Please consult your doctor. Glyree MV1 Tablet PR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glyree MV1 Tablet PR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glyree MV1 Tablet PR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glyree MV1 Tablet PR is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Glyree MV1 Tablet PR

Products matching your search